menu close
www.wugen.com

Wugen Stock

Company Profile:

Wugen is specializing in developing off-the-shelf cellular therapies for cancer treatment. Utilizing its proprietary Moneta™ platform, Wugen engineers memory natural killer (NK) and CAR-T cells derived from healthy donors to enhance anti-tumor activity without the risk of graft-versus-host disease. The company's investigational therapies target hematologic and solid tumor malignancies, aiming to provide accessible and effective treatment options for patients.

Sign up for SecondMarket® to view the market and buy or sell Wugen Stock
Buy + Sell
  • Headquarters: Saint Louis, MO
  • Year Founded: 2018
  • Industry: Biotechnology + Pharmaceuticals
Leverage Your Equity to Help Achieve More.

Wugen Funding

Sign up to gain insights into Wugen funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Financing Round Date Amount Price per share* Valuation*
Series C Aug 27, 2025 110.00M
Price
Valuation
Series C Aug 27, 2025 5.00M
Price
Valuation
Series B Jul 09, 2021 98.50M
Price
Valuation
Series A Apr 13, 2020 37.23M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

Wugen Management Team

  • Board Member

    Kevin Li

  • Board Member

    John McKearn

  • Board Member

    Peter Kiener

  • Board Member

    Drew Dennison

  • Board Member

    Bosun Hau

  • Board Member

    Bali Muralidhar

  • CEO

    Kumar Srinivasan

  • Co-Founder, Chief Scientific Officer

    Matthew Cooper

Wugen Major Investors

  • Abingworth Management

  • LYZZ Capital

  • Intermediate Capital Group

  • Tybourne Capital Management

  • Lightchain

  • RiverVest Venture Partners

  • Aisling Capital

  • Fidelity

Learn More About Wugen Stock

Buy Wugen Stock
01

Wugen stock does not trade on public stock exchanges. Wugen stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Wugen stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Wugen Stock
02

Wugen Stock does not trade on public stock exchanges. In order to sell Wugen shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Wugen Stock Price
03

Wugen does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Wugen share price and other valuable private market data.

Read more about secondary market private company stock prices:

Wugen Stock Ticker Symbol
04

There is no ticker symbol for Wugen stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Wugen Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Wugen stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Wugen Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Wugen stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Wugen Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Wugen IPO
08

Wugen is a private company and has not had an IPO. There is currently no Wugen IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Wugen IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Wugen Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Opentrons Labworks Inc-Logo

Opentrons Labworks

A developer of a pipetting robot technology designed to automate experiments.

Source: Nasdaq Private Market Tape D®